TECTONIC THERAPEUTIC INC (TECX) Stock Income Statement
NASDAQ:TECX - Nasdaq - US8789721086 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 58.02M | 125.57M | 32.83M | 15.61M | |||
| Research and Development | 40.16M | 35.99M | 25.02M | 10.81M | |||
| Selling, General, and Administrative Expenses | 16.65M | 7.67M | 7.16M | 4.62M | |||
| Operating Income | -58.02M | -125.57M | -32.83M | -15.61M | |||
| Interest Income/Expense | 4.15M | 429.00K | 5.00K | -860.00K | |||
| Other Income/Expense | -4.12M | 1.40M | 645.00K | 7.54M | |||
| Non Recurring Items | N/A | 80.92M | N/A | N/A | |||
| Income Before Taxes | -57.98M | -42.82M | -32.18M | -8.93M | |||
| Income Tax | N/A | 377.00K | N/A | N/A | |||
| Net Income | -57.98M | -42.82M | -32.18M | -8.93M | |||
| EBITDA | -56.37M | -124.09M | -31.82M | -15.25M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -6.83 | -2.91 | -2.18 | -0.61 | |||
| Non GAAP EPS | -8.18 | -3.78 | -2.41 | -2.79 | |||
| Statistics | |||||||
All data in USD